Bingcheng Lin Selected Research

Lab-On-A-Chip Devices

1/2022	Core fucosylation involvement in the paracrine regulation of proteinuria-induced renal interstitial fibrosis evaluated with the use of a microfluidic chip.
5/2019	Establishment and application of a dynamic tumor-vessel microsystem for studying different stages of tumor metastasis and evaluating anti-tumor drugs.
4/2011	Rapid screening of phenylketonuria using a CD microfluidic device.
5/2010	Characterization of the interaction between fibroblasts and tumor cells on a microfluidic co-culture device.
12/2009	A microfluidic device for characterizing the invasion of cancer cells in 3-D matrix.
12/2007	Cell-based high content screening using an integrated microfluidic device.
4/2007	Characterizing doxorubicin-induced apoptosis in HepG2 cells using an integrated microfluidic device.
9/2005	[Laboratory on a microfluidic chip].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bingcheng Lin Research Topics

Disease

14	Neoplasms (Cancer) 01/2021 - 09/2003
4	Leukemia 06/2010 - 03/2005
3	Carcinoma (Carcinomatosis) 11/2020 - 12/2007
3	Neoplasm Metastasis (Metastasis) 12/2019 - 11/2016
3	Hepatocellular Carcinoma (Hepatoma) 08/2007 - 09/2005
2	Breast Neoplasms (Breast Cancer) 01/2017 - 09/2007
1	Proteinuria 01/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2021
1	Liver Diseases (Liver Disease) 10/2019
1	Type 2 Diabetes Mellitus (MODY) 07/2018
1	Insulinoma 07/2018
1	Acute Kidney Injury (Acute Renal Failure) 02/2018
1	Wounds and Injuries (Trauma) 02/2018
1	Brain Neoplasms (Brain Tumor) 01/2018
1	Dehydration (Water Stress) 10/2011
1	Phenylketonurias (Phenylketonuria) 04/2011
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2010
1	Nerve Degeneration 11/2010
1	Inflammation (Inflammations) 06/2010
1	Hepatitis B 01/2006
1	Essential Hypertension 01/2005
1	Paramyxoviridae Infections (Parainfluenza) 09/2004

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 10/2019 - 12/2007
4	Biomarkers (Surrogate Marker)IBA 12/2019 - 01/2017
4	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2018 - 09/2005
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2018
3	DNA (Deoxyribonucleic Acid)IBA 11/2009 - 09/2003
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2020 - 02/2018
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2006 - 08/2006
2	Biological ProductsIBA 08/2006 - 09/2003
1	CytokinesIBA 01/2021
1	Bevacizumab (Avastin)FDA Link 11/2020
1	IntegrinsIBA 12/2019
1	Fluorouracil (Carac)FDA LinkGeneric 05/2019
1	MicroRNAs (MicroRNA)IBA 10/2018
1	RNA (Ribonucleic Acid)IBA 10/2018
1	Glucose (Dextrose)FDA LinkGeneric 07/2018
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 02/2018
1	Cisplatin (Platino)FDA LinkGeneric 02/2018
1	nephrinIBA 02/2018
1	Cadherins (E-Cadherin)IBA 02/2018
1	Epithelial Cell Adhesion MoleculeIBA 01/2017
1	plerixafor FDA Link 11/2016
1	Capsules (Microcapsules)IBA 10/2011
1	NeurotoxinsIBA 11/2010
1	Matrix Metalloproteinase InhibitorsIBA 07/2010
1	methionyl-leucyl-phenylalanineIBA 06/2010
1	Peptides (Polypeptides)IBA 06/2010
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 06/2010
1	Epidermal Growth Factor (EGF)IBA 12/2009
1	Arsenic Trioxide (Trisenox)FDA Link 09/2007
1	Cysteine (L-Cysteine)FDA Link 09/2007
1	Sulfates (Sulfates, Inorganic)IBA 08/2006
1	Dextrans (Dextran)FDA Link 08/2006
1	Therapeutic UsesIBA 08/2006
1	Polymethyl Methacrylate (Sol)IBA 01/2006
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2005
1	Glutathione (Reduced Glutathione)IBA 03/2005
1	AngiotensinogenIBA 01/2005
1	Complementary DNA (cDNA)IBA 09/2004

Therapy/Procedure

8	Lab-On-A-Chip Devices 01/2022 - 09/2005
5	Therapeutics 01/2018 - 12/2009
1	Precision Medicine 05/2019
1	Immunotherapy 01/2018